Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Pediatric Hematology/Oncology
•
Thrombosis
•
Hematology
•
Pediatric Hematology
Do you recommend indefinite anticoagulation for patients with homozygous Factor V Leiden mutation who have had a provoked VTE?
Related Questions
What are your top takeaways from ISTH 2025?
How do you counsel an otherwise healthy patient on how soon they can go back to moderate exercise after a bilateral pulmonary embolism?
How would you counsel a woman with a strong family history of thrombosis about oral contraceptives?
In what clinical scenario would you consider liver transplant evaluation for a patient with sickle cell hepatopathy?
If a pediatric patient has a prior history of cancer-associated thrombosis while receiving active treatment, can they be on estrogen-containing OCPs in the future?
Is there any indication for IVIG in immunocompromised patients with only decreased IgM and/or IgA levels?
What workup needs to be performed on pediatric patients with warm autoimmune hemolytic anemia prior to initiation of treatment with immunosuppressants?
What are your top takeaways in Classical Hematology from ASH 2025?
How would you manage aplastic anemia refractory to multiple agents?
For transplant-ineligible aplastic anemia planned for immunosuppression, how do you approach duration and tapering of cyclosporine and eltrombopag?
